The differences in infiltration of CD8+ and CD4+ T cells led to a CD4/CD8 ratio that was high in EO771 tumors, intermediate in B16 tumors, and low in the other tumor models (Figure 2O). The gene discussed is CD8A; the disease is neoplasm.